KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

Novartis Ag (NVS) Inventory Average (2018 - 2026)

Novartis Ag's Inventory Average history spans 9 years, with the latest figure at $2.7 billion for Q1 2026.

  • On a quarterly basis, Inventory Average changed N/A to $2.7 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $2.7 billion, a N/A change, with the full-year FY2025 number at $2.8 billion, up 6.84% from a year prior.
  • Inventory Average hit $2.7 billion in Q1 2026 for Novartis Ag, down from $3.1 billion in the prior quarter.
  • Over the last five years, Inventory Average for NVS hit a ceiling of $12.9 billion in Q3 2022 and a floor of $2.7 billion in Q1 2026.
  • Historically, Inventory Average has averaged $4.7 billion across 4 years, with a median of $3.2 billion in 2025.
  • The widest YoY moves for Inventory Average: up 22.23% in 2023, down 68.0% in 2023.
  • Tracing NVS's Inventory Average over 4 years: stood at $3.8 billion in 2022, then decreased by 22.23% to $3.0 billion in 2023, then grew by 5.92% to $3.1 billion in 2025, then dropped by 12.69% to $2.7 billion in 2026.
  • Business Quant data shows Inventory Average for NVS at $2.7 billion in Q1 2026, $3.1 billion in Q4 2025, and $3.2 billion in Q3 2025.